Skip to content

Clinical trials

Terminated Carcinoma, Hepatocellular trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Terminated Country / region: United States Clear all

158 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20022
20032
20044
20051
200710
20088
20099
20108
20115
20135
20147
20155
20169
201710
201811
201915
20208
202112
20229
202311

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated158

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
Stanford University6
M.D. Anderson Cancer Center4
Case Comprehensive Cancer Center3
Incyte Corporation3
Mayo Clinic3
Pfizer3
University of California, San Francisco3
University of Texas Southwestern Medical Center3
Washington University School of Medicine3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular158
Liver Neoplasms42
Stomach Neoplasms17
Carcinoma, Non-Small-Cell Lung16
Carcinoma, Renal Cell16
Colorectal Neoplasms15
Melanoma14
Neoplasms14
Cholangiocarcinoma12
Squamous Cell Carcinoma of Head and Neck12

Trials

Showing 1 to 25 of 158. Each trial links to its page on Pharma Observatory.

58 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.